Time filter

Source Type

News Article | February 26, 2017
Site: www.marketwired.com

BARCELONA, SPAIN--(Marketwired - Feb 26, 2017) - Telecommunications carriers and enterprises need to accelerate cloud-based network virtualization deployments to support new service innovations as technologies such as 5G and IoT increase the pace of digital transformation for businesses, ICT solutions provider ZTE Corporation said before the opening of Mobile World Congress 2017. "The Internet of Everything is becoming a reality as humans, businesses, machines and sensors are being connected by smart heterogeneous networks, running increasingly powerful applications developed on open platforms and ecosystems," Xu Ming, President of Strategy and Marketing at ZTE, told journalists and analysts at an event in Barcelona, ahead of MWC 2017. "To compete effectively, businesses and organizations need to accelerate digital transformation by deploying virtualized technology infrastructure, and use the power of artificial intelligence to optimize their operations," Xu said. ZTE, a key supplier to top carriers including Telefonica, SoftBank, China Mobile, Hutchison and VimpelCom, is showcasing new solutions for 5G and cloud-based networks at MWC, Xu said. ZTE will release a full range of 5G pre-commercial base stations for millimeter Wave and sub-6 Ghz frequencies at MWC, said Zhang Jianguo, Senior Vice President of Wireless Products. The new ZTE 5G base stations are capable of 50 Gbps peak data transmission rates, Zhang said. The new solutions support 3GPP (3rd Generation Partnership Projects)'s new radio (NR) new air interfaces and mainstream 5G frequency bands. "ZTE's solutions are 5G-ready, giving our customers a first-mover advantage," Zhang said. The new ZTE 5G products use Massive MIMO, Beam Tracking, beamforming and other key 5G technologies, meeting 5G pre-commercial deployment requirements, Zhang said. ZTE recently became the world's first provider of FDD-LTE-based Massive MIMO solution, building on the company's leadership in 5G research. The company's proprietary Pre5G solutions enable carriers to deploy 5G technologies on existing 4G LTE infrastructure, and are deployed in more than 40 networks in 30 countries by carriers including SoftBank, China Mobile and Telefonica. ZTE will also launch 5G Flexhaul, the world's first fronthaul and backhaul integrated solution based on Internet protocol (IP)+Optical technology. ZTE's new 5G Flexhaul solution provides unified transport of 5G fronthaul and backhaul services, as well as super-large bandwidth, ultra-low latency and software-defined networking (SDN)-based traffic engineering. At MWC 2017, ZTE will also showcase new IoT solutions based on Narrowband-IoT (NB-IoT), and will run demonstrations for Smart Parking, Metering, Lighting and Water Pollution Control, Xu said. During MWC 2017, ZTE and GSMA are co-hosting the 2017 Global IoT Summit, where partners including Qualcomm, Intel and Alibaba Cloud will share their latest strategies and best practices for IoT. "ZTE is a leader in innovations in network virtualization and cloud network architecture technologies to help operators revamp their network infrastructure, network functions and operations," Zhang said. "This is key for digital transformation for operators and enterprises." ZTE's NETWORK 2020 and ElasticNet solutions use SDN and NFV technologies to enable deployments in virtual data centers, bearer networks, wireless core networks and orchestration. ZTE's NFV and SDN solutions are deployed in more than 180 commercial and trial networks globally. In 2016, ZTE worked with carriers on more than 40 new network virtualization deployments around the world, Zhang said. For example, ZTE is working with Telefonica on cloud network architecture projects in seven Latin American markets. ZTE is also partnering with VimpelCom on a vEPC converged network covering five countries, which is one of the biggest network of its type in the world. With 20 global R&D centers, ZTE employs over 30,000 research professionals in the development of next-generation technologies including 5G, the Internet of Things, NFV, SDN, Cloud Computing, Big Data and Smart City. ZTE has filed applications for more than 68,000 patents, with over 25,000 granted. Since 2010, ZTE has been ranked among the world's Top-3 for patent applications under the Patent Cooperation Treaty (PCT) each year, according to the World Intellectual Property Organization. At MWC 2017, ZTE will unveil a new Gigabit smartphone, setting a milestone in the global mobile devices industry. The new ZTE Gigabit phone delivers superior user experience, featuring 360° panoramic VR video, instant cloud storage, entertainment upgrades and fast cache of ultra Hi-Fi music and movies, said Luo Wei, the Product head for Devices and Terminals for ZTE North America. Visitors to ZTE's stand at MWC 2017 can also experience the newly updated Axon 7, ZTE's flagship smartphone, with support for Android Nougat and Google Daydream. "ZTE will accelerate innovations in our core operations to help operators and enterprises with digital transformation, delivering business advantages and increased efficiencies for customers," Xu said. "We are also working on opportunities to grow our business from new technologies such as virtual reality, augmented reality, IoT, Big Data and artificial intelligence." About ZTE: ZTE is a provider of advanced telecommunications systems, mobile devices, and enterprise technology solutions to consumers, carriers, companies and public sector customers. As part of ZTE's M-ICT strategy, the company is committed to provide customers with integrated end-to-end innovations to deliver excellence and value as the telecommunications and information technology sectors converge. Listed in the stock exchanges of Hong Kong and Shenzhen (H share stock code: 0763.HK / A share stock code: 000063.SZ), ZTE's products and services are sold to over 500 operators in more than 160 countries. ZTE commits 10 per cent of its annual revenue to research and development and has leadership roles in international standard-setting organizations. ZTE is committed to corporate social responsibility and is a member of the UN Global Compact. For more information, please visit www.zte.com.cn


News Article | February 27, 2017
Site: www.marketwired.com

BARCELONA, SPAIN--(Marketwired - Feb 27, 2017) -  Telecommunications carriers and enterprises need to accelerate cloud-based network virtualization deployments to support new service innovations as technologies such as 5G and IoT increase the pace of digital transformation for businesses, ICT solutions provider ZTE Corporation said before the opening of Mobile World Congress 2017. "The Internet of Everything is becoming a reality as humans, businesses, machines and sensors are being connected by smart heterogeneous networks, running increasingly powerful applications developed on open platforms and ecosystems," Xu Ming, President of Strategy and Marketing at ZTE, told journalists and analysts at an event in Barcelona, ahead of MWC 2017. "To compete effectively, businesses and organizations need to accelerate digital transformation by deploying virtualized technology infrastructure, and use the power of artificial intelligence to optimize their operations," Xu said. ZTE, a key supplier to top carriers including Telefonica, SoftBank, China Mobile, Hutchison and VimpelCom, is showcasing new solutions for 5G and cloud-based networks at MWC, Xu said. ZTE will release a full range of 5G pre-commercial base stations for millimeter Wave and sub-6 Ghz frequencies at MWC, said Zhang Jianguo, Senior Vice President of ZTE. The new ZTE 5G base stations are capable of 50 Gbps peak data transmission rates, Zhang said. The new solutions support 3GPP (3rd Generation Partnership Projects)'s new radio (NR) new air interfaces and mainstream 5G frequency bands. "ZTE's solutions are 5G-ready, giving our customers a first-mover advantage," Zhang said. The new ZTE 5G products use Massive MIMO, Beam Tracking, beamforming and other key 5G technologies, meeting 5G pre-commercial deployment requirements, Zhang said. ZTE recently became the world's first provider of FDD-LTE-based Massive MIMO solution, building on the company's leadership in 5G research. The company's proprietary Pre5G solutions enable carriers to deploy 5G technologies on existing 4G LTE infrastructure, and are deployed in more than 40 networks in 30 countries by carriers including SoftBank, China Mobile and Telefonica. ZTE will also launch 5G Flexhaul, the world's first fronthaul and backhaul integrated solution based on Internet protocol (IP)+Optical technology. ZTE's new 5G Flexhaul solution provides unified transport of 5G fronthaul and backhaul services, as well as super-large bandwidth, ultra-low latency and software-defined networking (SDN)-based traffic engineering. At MWC 2017, ZTE will also showcase new IoT solutions based on Narrowband-IoT (NB-IoT), and will run demonstrations for Smart Parking, Metering, Lighting and Water Pollution Control, Xu said. During MWC 2017, ZTE and GSMA are co-hosting the 2017 Global IoT Summit, where partners including Qualcomm, Intel and Alibaba Cloud will share their latest strategies and best practices for IoT. "ZTE is a leader in innovations in network virtualization and cloud network architecture technologies to help operators revamp their network infrastructure, network functions and operations," Zhang said. "This is key for digital transformation for operators and enterprises." ZTE's NETWORK 2020 and ElasticNet solutions use SDN and NFV technologies to enable deployments in virtual data centers, bearer networks, wireless core networks and orchestration. ZTE's NFV and SDN solutions are deployed in more than 180 commercial and trial networks globally. In 2016, ZTE worked with carriers on more than 40 new network virtualization deployments around the world, Zhang said. For example, ZTE is working with Telefonica on cloud network architecture projects in seven Latin American markets. ZTE is also partnering with VimpelCom on a vEPC converged network covering five countries, which is one of the biggest networks of its type in the world. With 20 global R&D centers, ZTE employs over 30,000 research professionals in the development of next-generation technologies including 5G, the Internet of Things, NFV, SDN, Cloud Computing, Big Data and Smart City. ZTE has filed applications for more than 68,000 patents, with over 25,000 granted. Since 2010, ZTE has been ranked among the world's Top-3 for patent applications under the Patent Cooperation Treaty (PCT) each year, according to the World Intellectual Property Organization. At MWC 2017, ZTE will unveil a new Gigabit smartphone, setting a milestone in the global mobile devices industry. The new ZTE Gigabit phone delivers superior user experience, featuring 360° panoramic VR video, instant cloud storage, entertainment upgrades and fast cache of ultra Hi-Fi music and movies, said Luo Wei, the Product head for Devices and Terminals for ZTE North America. Visitors to ZTE's stand at MWC 2017 can also experience the newly updated Axon 7, ZTE's flagship smartphone, with support for Android Nougat and Google Daydream. "ZTE will accelerate innovations in our core operations to help operators and enterprises with digital transformation, delivering business advantages and increased efficiencies for customers," Xu said. "We are also working on opportunities to grow our business from new technologies such as virtual reality, augmented reality, IoT, Big Data and artificial intelligence." ZTE is a provider of advanced telecommunications systems, mobile devices, and enterprise technology solutions to consumers, carriers, companies and public sector customers. As part of ZTE's M-ICT strategy, the company is committed to provide customers with integrated end-to-end innovations to deliver excellence and value as the telecommunications and information technology sectors converge. Listed in the stock exchanges of Hong Kong and Shenzhen (H share stock code: 0763.HK / A share stock code: 000063.SZ), ZTE's products and services are sold to over 500 operators in more than 160 countries. ZTE commits 10 per cent of its annual revenue to research and development and has leadership roles in international standard-setting organizations. ZTE is committed to corporate social responsibility and is a member of the UN Global Compact. For more information, please visit www.zte.com.cn


Receive press releases from IQ4I Research & Consultancy Pvt. Ltd.: By Email IQ4I Research & Consultancy Published a New Report on "Electrosurgical Devices Global Market – Forecast to 2023" Electrosurgery includes use of alternating electrical energy to perform surgeries such as cardiac, orthopedic, cosmetic, dermatological, gynaecology and others. These devices are used for surgical cutting, manage blood loss by coagulation reducing patient recovery time. Boston, MA, December 25, 2016 --( Increase in the number of patients suffering from obesity, the rise in aging population, increasing demand for minimally invasive procedures, growing preference for cosmetic surgery procedures and advancements of technologies are driving the growth of the electrosurgical devices global market. However, the risks and complications associated with electrosurgery, product recalls, healthcare reforms, especially in U.S., preference for non-invasive procedures and pricing pressure on medical device manufacturers due to excise tax leverage, are restraining the growth of electrosurgical devices global market. Technological advancements in electrosurgical devices market products such as bipolar instruments, argon enhancement systems; Helium based plasma systems, smoke evacuation systems with benefits that include quick and efficient coagulation, a thinner, less charring and less tissue damage. The new Helium based plasma system lowers the risk of injury to surrounding tissue, and less smoke during the electrosurgical process and focuses on RF energy for greater control of tissue effect, enabling a high level of precision and virtually eliminates tissue trauma. In addition, the advanced smoke evacuation systems introduced recently filters the surgical smoke (plume) to remove odor, particulates, and other potentially hazardous by-products of electrosurgery procedures and the exposure to plume poses that risks health of surgeons, nurses, as well as patients. For instance, Medtronic is offering the RapidVac smoke evacuator system, designed to filter the surgical smoke that contains toxic chemicals, viable bacteria, viruses, and mutagenic substances. Technological advancements in electrosurgical procedures includes, Minimally-Invasive procedures such as laparoscopic and robotic assisted surgery which are becoming popular globally as they offer the better clinical outcomes than open surgical procedures where electrosurgical devices are invariably used. The advancements in products and technology have become an essential component and the latest innovation enhances the performance of these electrosurgical devices which leads to the higher adoption of electrosurgery. As the electrosurgical devices global market is dominated by few major players, the market is considered to be consolidated and the protection of intellectual property rights plays a very important role as a long term strategy for survival of the company and to maintain a competitive advantage. According to IQ4I Analysis, Olympus Corporation filed the largest number of PCT applications followed by Medtronic, J & J (Ethicon) and Bovie Medical at World Intellectual Property Organization (WIPO). Among the electrosurgical products, instrument/units held the largest market share and are expected to grow at medium single digit CAGR. In electrosurgical instruments market, the bipolar instruments held the largest market share. Along with the wide application of monopolar instruments, even the advancements in bipolar instruments are leading to the adaption of electrosurgical instrument and also the innovative technologies involved in the production of the different instruments such as multifunctional electrodes and pencils help the electrosurgical instruments segment grow rapidly over other product segments. Among various surgeries, Oncology held the largest market share; Cosmetic & dermatology surgery segment is expected to grow at the highest CAGR during the forecast period due to the rising awareness and growing adoption rate of these treatments. In electrosurgical devices global market by geography, the North America region held the largest market share due to the availability of highly advanced healthcare facilities, growing awareness about the technological advancements, availability of Medicare and third party insurance facilities, easy availability of skilled personnel and Asia-Pacific region is expected to grow at high single digit CAGR due to increase in healthcare spending and advancements in healthcare facilities. Some of the major companies operating in the electrosurgical devices market are B. Braun Melsungen AG (Germany), Bovie Medical Corporation (U.S.), Bowa Electronic GMBH & Co. KG (Germany), Conmed Corporation (U.S.), Medtronic (Covidien) (Ireland), Erbe Electromedizin GMBH (Germany), Johnson & Johnson (Ethicon) (U.S.), Olympus Corporation (Japan), Smith & Nephew PLC (U.K.), Symmetry Surgical Inc. (U.S.), Utah Medical Products Inc. (U.S.). and are considered to be the leaders in this space with their marketed products and strong pipelines. Some of the emerging players in electrosurgical devices are UZUMCU (Turkey), Telea electronics engineering (Italy), Symmetry surgical (U.S), Olives (India), Applied Medical (U.S.), Atricure (U.S.), Stryker (U.S.), Arthrex (U.S.), Depuy Synthes (U.S.), Wisap medical technology (Germany), SKLAR (U.S.), Richard Wolf medical instruments corporation (U.S.), Maxer (Germany), Etc., Boston, MA, December 25, 2016 --( PR.com )-- Electrosurgery procedures employ devices where electrical energy is used to achieve the desired clinical effect in which a radio-frequency (RF)/ alternating current at various voltage ranging from 200-10,000V is passed through the biological tissues to cut, coagulate, desiccate, or even to fuse tissue. Its benefit includes the ability to make precise cuts with limited blood loss during surgery. In electrosurgical procedures, the tissue is heated by an alternate current. The main advantage of using electrosurgical devices over electrocautery devices is that they reduces damage to the surrounding tissues as these devices are highly precise where the Low voltage is preferred for cut modes and a high voltage is preferred for coagulation mode. According to IQ4I analysis, the electrosurgical devices global market is expected to grow at a medium CAGR % to reach $6,178.2 million by 2023.Increase in the number of patients suffering from obesity, the rise in aging population, increasing demand for minimally invasive procedures, growing preference for cosmetic surgery procedures and advancements of technologies are driving the growth of the electrosurgical devices global market. However, the risks and complications associated with electrosurgery, product recalls, healthcare reforms, especially in U.S., preference for non-invasive procedures and pricing pressure on medical device manufacturers due to excise tax leverage, are restraining the growth of electrosurgical devices global market.Technological advancements in electrosurgical devices market products such as bipolar instruments, argon enhancement systems; Helium based plasma systems, smoke evacuation systems with benefits that include quick and efficient coagulation, a thinner, less charring and less tissue damage. The new Helium based plasma system lowers the risk of injury to surrounding tissue, and less smoke during the electrosurgical process and focuses on RF energy for greater control of tissue effect, enabling a high level of precision and virtually eliminates tissue trauma. In addition, the advanced smoke evacuation systems introduced recently filters the surgical smoke (plume) to remove odor, particulates, and other potentially hazardous by-products of electrosurgery procedures and the exposure to plume poses that risks health of surgeons, nurses, as well as patients. For instance, Medtronic is offering the RapidVac smoke evacuator system, designed to filter the surgical smoke that contains toxic chemicals, viable bacteria, viruses, and mutagenic substances.Technological advancements in electrosurgical procedures includes, Minimally-Invasive procedures such as laparoscopic and robotic assisted surgery which are becoming popular globally as they offer the better clinical outcomes than open surgical procedures where electrosurgical devices are invariably used. The advancements in products and technology have become an essential component and the latest innovation enhances the performance of these electrosurgical devices which leads to the higher adoption of electrosurgery.As the electrosurgical devices global market is dominated by few major players, the market is considered to be consolidated and the protection of intellectual property rights plays a very important role as a long term strategy for survival of the company and to maintain a competitive advantage.According to IQ4I Analysis, Olympus Corporation filed the largest number of PCT applications followed by Medtronic, J & J (Ethicon) and Bovie Medical at World Intellectual Property Organization (WIPO).Among the electrosurgical products, instrument/units held the largest market share and are expected to grow at medium single digit CAGR. In electrosurgical instruments market, the bipolar instruments held the largest market share. Along with the wide application of monopolar instruments, even the advancements in bipolar instruments are leading to the adaption of electrosurgical instrument and also the innovative technologies involved in the production of the different instruments such as multifunctional electrodes and pencils help the electrosurgical instruments segment grow rapidly over other product segments.Among various surgeries, Oncology held the largest market share; Cosmetic & dermatology surgery segment is expected to grow at the highest CAGR during the forecast period due to the rising awareness and growing adoption rate of these treatments. In electrosurgical devices global market by geography, the North America region held the largest market share due to the availability of highly advanced healthcare facilities, growing awareness about the technological advancements, availability of Medicare and third party insurance facilities, easy availability of skilled personnel and Asia-Pacific region is expected to grow at high single digit CAGR due to increase in healthcare spending and advancements in healthcare facilities.Some of the major companies operating in the electrosurgical devices market are B. Braun Melsungen AG (Germany), Bovie Medical Corporation (U.S.), Bowa Electronic GMBH & Co. KG (Germany), Conmed Corporation (U.S.), Medtronic (Covidien) (Ireland), Erbe Electromedizin GMBH (Germany), Johnson & Johnson (Ethicon) (U.S.), Olympus Corporation (Japan), Smith & Nephew PLC (U.K.), Symmetry Surgical Inc. (U.S.), Utah Medical Products Inc. (U.S.). and are considered to be the leaders in this space with their marketed products and strong pipelines. Some of the emerging players in electrosurgical devices are UZUMCU (Turkey), Telea electronics engineering (Italy), Symmetry surgical (U.S), Olives (India), Applied Medical (U.S.), Atricure (U.S.), Stryker (U.S.), Arthrex (U.S.), Depuy Synthes (U.S.), Wisap medical technology (Germany), SKLAR (U.S.), Richard Wolf medical instruments corporation (U.S.), Maxer (Germany), Etc., Click here to view the list of recent Press Releases from IQ4I Research & Consultancy Pvt. Ltd.


Company's Major Investment company Announces Filing of Protection for Proprietary Method of THC Extraction that will Achieve Highest THC Purity Level on the Market SAN DIEGO, CA--(Marketwired - November 29, 2016) - Medical Marijuana, Inc. ( : MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) ( : AXIM) has filed an IP application with the World Intellectual Property Organization (WIPO) on a proprietary method to extract THC-A (tetrahydrocannabinol acid) from cannabis plants and to achieve THC (tetrahydrocannabinol) with higher purity than conventional methods being used in the market today. THC is the most commonly known Cannabinoid derived from the Cannabis plant. The recently-filed IP would give protection to the invention of a method of extraction of THC-A from the cannabis flower using a solvent where the yield is approximately 50 - 70% with regards to THC-A content in the starting material. A neutral metal salt or inorganic base solution saturated with the metal neutral salt and adjusted to basic pH enables separation of the THC-A layer and significantly increases the yield. THC-A is then decarboxylated in a water/ethanol solution to render THC at a purity greater than 95%. The IP was generated in collaboration with Syncom B.V., a Netherlands-based premier company in custom synthesis solutions for the pharmaceutical and biotech industry. "We are extremely excited to see that AXIM has filed this IP as it represents the first stage of a chain of processes in development of novel and revolutionary drug products all based on AXIM's propriety IP," said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. "This is another example of how AXIM is at the forefront of the cannabis biotechnology industry. This extraction method will change how THC can be utilized in products in the future and open up new possibilities for the industry as a whole." He continued, "The THC purity level that AXIM is able to achieve through this invention will untimely represent a milestone achievement in the standardizing of cannabis based products. With roughly 440 marijuana strains in existence with varying levels of Cannabinoids, trying to make this into a standardized medicine has represented a real challenge for the research community. Now AXIM has overcome these hurdles and we believe this will allow for future cannabis based drug development opportunities. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products. AXIM® Biotechnologies, Inc. ( : AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. We prioritize the well-being of our customers while embracing a solid fiscal strategy. Medical Marijuana, Inc. is a major investor in AXIM. For more information, visit www.AXIMBiotech.com. This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein. These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


News Article | February 15, 2017
Site: www.marketwired.com

CHICAGO, IL--(Marketwired - February 08, 2017) - Associate Professor Daryl Lim, Director of the Center for Intellectual Property, Information & Privacy Law at The John Marshall Law School in Chicago, will speak at the American Antitrust Institute's annual conference. The theme of this year's conference, which will be held on February 8 in Washington, D.C. is "Critical Issues in Global Antitrust: Comity, Intellectual Property and Due Process." Lim will speak about the latest antitrust investigations involving Qualcomm in the United States and overseas. Other prominent speakers include those from academia, government and practice. Lim is considered a leader in the fields of antitrust and patent law. His book Patent Misuse and Antitrust Law: Empirical, Doctrinal and Policy Perspectives has been lauded in "World Competition Law and Economics Review," a leading journal focusing on competition law. His book has been cited to the U.S. Supreme Court by lawyers for both sides in their briefs in Kimble v. Marvel Enterprises, Inc., a case concerning post-expiration patent royalty payments. He has written nearly 30 articles and participated at over 50 conferences and talks. His work also has been cited in several reports, including those by the Organisation for Economic Co- operation and Development, the World Intellectual Property Organization and the Canadian government. He became director of John Marshall's intellectual property program in October 2015. John Marshall is one of just three law schools in Chicago to be ranked in IP law by U.S. News & World Report. John Marshall, ranked 21 out of over 200 law schools is also one of 42 law schools in the country to participate in the U.S. Patent and Trademark Office (USPTO) Law School Clinic Certification Program. It is the only law school in Illinois whose USPTO program focuses on both patent and trademark practice areas. With more than 50 specialized IP courses, John Marshall's program draws students from around the U.S. and across the globe. It has partnered with IP lawyers in the People's Republic of China for 20 years. It also conducts an ABA-approved summer program in China dedicated to IP issues.


News Article | December 5, 2016
Site: en.prnasia.com

SEOUL, South Korea, Dec. 5, 2016 /PRNewswire/ -- KIPA (Korea Invention Promotion Association), Chairman, Jayeol Gu, announced on December 5th that the Seoul International Invention Fair (SIIF) 2016, held at COEX in Seoul (Hall A) from December 1st to 4th, has become one of the world's largest international invention fairs, alongside international invention events held in the US, Switzerland and Germany. Celebrating its 12th anniversary this year, SIIF 2016 is an international event officially sponsored by WIPO (World Intellectual Property Organization) and IFIA (International Federation of Inventors' Associations) and successfully displayed a total of 639 inventions from 31 participating countries such as the USA, Germany. This year's event also saw the inclusion of 176 inventions from 120 local (South Korea) companies. Together with the main exhibition, there was the showcase of the International Invention & Business Pavilion with 20 inventions from foreigners living in Korea who wished to attain local patent rights or open up their own business. The Grand Prize winner of SIIF this year was BSCARE from South Korea, and this award-winning invention is going to be used as an ingrown toe nail retractor. Plasmapp Co., Ltd. from South Korea, Su Shiung Lam from Malaysia, Huang Cong-Hui / Wang Tzu-Yuan / Yu Shang-Ju / Chen Bo-Zhang / Wang Li-Ming / Su Yu-Tang / Liang Chun-Ting / Ding Zi-Hao from Taiwan, and Petai Pongpiachan / Siam Novas Co. Ltd. from Thailand all won the Grand Prize. This year, especially with the heightened sense of alarm due to the numerous global disasters such as earthquakes, a series of safety related items, such as an Earthquake Flashlight received a great deal of attention and achieved success as prize winners. The exhibition also offered the participants various opportunities from entering into the open market, technology transfer, access to crowdfunding for business meetings for purchases or investments as well as an opportunity to display their works in an exhibition and as an advertisement. Junseok Lee, President of KIPA says, "In order to help the participants find their way into the world market, SIIF will give continuous support to them by cooperating closely with related international organizations and the invention groups of each country." To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/a-successful-conclusion-to-the-seoul-international-invention-fair-2016-300372498.html


News Article | November 29, 2016
Site: en.prnasia.com

SEOUL, South Korea, Nov 29, 2016 /PRNewswire/ -- The Korea Invention Promotion Association (KIPA) announced that the Seoul International Invention Fair (SIIF) 2016 will be held at the Coex (Hall A) in Seoul, South Korea, from 1st to the 4th December. SIIF is one of the world's largest international invention fairs. World Intellectual Property Organization (WIPO) and International Federation of Inventors' Associations (IFIA) are officially sponsoring this event. SIIF 2016 will display a total of 639 pieces of inventions from 31 participating countries like the USA, Germany, including 176 inventions from 120 local (South Korean) companies. Together with the main exhibition, there will be the International Invention & Business Pavilion which will showcase 20 types of inventions from foreigners living in South Korea who wish to attain local patent rights or open up their own business. The participants of SIIF will encounter various opportunities from entering into the open market, technology transfer, access to crowdfunding or business meetings for purchase or investment. Junseok Lee, President of KIPA stated that, "As an event that showcases global state-of-the-art technology, SIIF has been putting efforts into building up the international status of the exhibition, working on close cooperation with related international organizations and invention groups from each country," adding that "we will do our utmost to help the participants find their way into the world market." SIIF 2016 offers free admission to the visitors. For more information, visit SIIF's official website www.siif.org/eng or call +82-2-3459-2796 (2842), KIPA's department of Intellectual Property Promotion. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/seoul-international-invention-fair-2016-to-be-held-on-dec-1-300368771.html


News Article | February 16, 2017
Site: www.sciencemag.org

France isn't the hotbed of innovation it would like to be, and one reason is that scientific research has traditionally been done by public servants, who rarely start a company to turn their discoveries into new products or services. A 1999 law that aimed to change that by stimulating entrepreneurship has not had the intended effects, according to a report released on Tuesday. The report recommends relaxing the rules for academics who want to embark on a commercial adventure, rewarding those who file patents, and giving entrepreneurial scientists more recognition. Judged solely by the number of patent filings, France may seem quite an entrepreneurial country; it ranks sixth globally, according to the latest figures from the World Intellectual Property Organization. But public researchers are often loath to become entrepreneurs. The French government asked Jean-Luc Beylat, president of Nokia Bell Labs France in Paris, and Pierre Tambourin, general director of the biocluster Genopole in Evry, to review the so-called Allègre Law of 1999, which sought to make it easier for scientists to engage in entrepreneurship, as well as similar initiatives. Until then, researchers at French universities and public research institutions had to be fully committed to academia and were not allowed to benefit economically from their discoveries. The law, named after then–Science Minister Claude Allègre, was inspired by U.S. successes in harnessing research to boost innovation and economic growth. It allows researchers to pause their academic duties for up to 6 years to launch a startup and invest money in it, as long as they obtain the blessing of their institution and the Public Service Ethics Commission. After that, they can stay involved in the company for up to 10 years as a consultant if they have a capital share of below 49%, and become an executive board member if their share is below 20%. But they must sell their stake in the company once they stop working for it altogether. On average, only 98 academics per year have applied for the Public Service Ethics Commission’s blessing to use these options, with only 89 receiving it—a "very low" and "disappointing" outcome, the report says. Moreover, more than 80% of the authorizations were given for consulting activities, versus 3.5% for sitting on an executive board and 16.2% for actually creating a startup. That's far less than the law intended, says the report, and a missed opportunity for publicly funded research. The authors suggest further loosening the rules. Researchers should be allowed to spend up to 10 years on developing their spin-off and to work 50% of their time on consulting activities, instead of the current 20%, for instance. They should also be given 3 years to resell their share and be allowed to keep up to 20% of it. The Public Service Ethics Commission should play a smaller role, the authors say, and entrepreneurial activities should be a factor in the career advancement of publicly funded researchers. “These are good measures,” says Xavier Duportet, co-founder and chief executive officer at Eligo Bioscience in Paris, who was hailed as one of France's top young entrepreneurs in and . But other things may be more important, he adds, such as mentorship of starting entrepreneurs by experienced colleagues and a more interdisciplinary approach in French higher education. Above all, France's academic culture needs to change, he adds. “When you enroll as a civil servant, it is not really in the current culture that one day you could become an entrepreneur,” says Duportet, who also founded a nonprofit to help scientists across the world launch their own startups.


News Article | November 28, 2016
Site: marketersmedia.com

Online entrepreneur Matt Lloyd, with more than five years of experience building online business models, has launched a webinar to teach entrepreneurs about the benefits of licensing rights and how to strategize and leverage a profitable business system. More information about the webinar is available at: http://twe.to/pca4. Licensing of intellectual property rights is a tool used by small and medium-sized enterprises for starting a new business, expanding an existing business, extending territory or the nature of business or improving the quality of goods or services according to the World Intellectual Property Organization (WIPO). The worth of intellectual property to the U.S. economy is approximated to be more than $5 trillion in the United States and creates employment for an estimated 18 million American people as reported by the United States Patent & Trademark Office. The value is considered similarly high in other nations. Matt Lloyd’s webinar is entitled “The Business Model That Took Me From Making $700/mo to $314,900.29/mo In Less Thank 18 Months…” The free webinar for home business entrepreneurs reveals how they can leverage a business system, make it proven and profitable and eliminate the time and frustration of creating their own products. The webinar focuses on the benefits of a licensing rights program. Intellectual property rights (IPRs) are the protections granted to the creators of IP. There are different types of licensing rights including trademarks, copyright, patents, industrial design rights and in some jurisdictions trade secrets. Also considered under intellectual property are artistic works including music and literature, as well as discoveries, inventions, words, phrases, symbols and designs. Matt Lloyd’s webinar goes through insights and strategies to apply to business he learned after experiencing a rollercoaster income until after 2011 when he applied strategies that moved his income into upward exponential growth. It discusses unconventional ways to get results. The webinar reveals that 97% of people who get started online with internet marketing fail. It explains a business system to duplicate and leverage the information presented in the webinar. It discusses producing a sales funnel including creating traffic, setting up automated Emails, following up and utilizing tools like webinars. More than 60% of marketers use webinars as part of their content marketing programs according to the Content Marketing Institute. Of the lead generation tactics available, webinars are the second most effective type of premium content for marketers. The webinar includes a link to a full video recording “The Truth About Traffic.” It can be found at the website listed above. For more information, please visit http://twe.to/pca4


News Article | September 28, 2016
Site: www.nature.com

Competition over the bandwidths used by mobile phones and time-critical weather transmissions is only part of the story (see Nature 535, 208–209; 2016). In fact, mobile networks are themselves becoming an important tool for monitoring the weather. Because weather conditions reduce the strength of radio signals transmitted by commercial microwave links in cellular networks, they can act as a virtual environmental-monitoring facility. For instance, commercial cellular data are already being used to track precipitation, fog, near-surface moisture (see, for example, et al. Bull. Am. Meteorol. Soc. 96, 1687–1698; 2015) and dew ( et al. IEEE Sel. Top. Appl. Earth Obs. Remote Sens. 8, 4396–4404; 2015), and to predict floods (a discovery awarded the World Intellectual Property Organization Medal in 2009).

Loading World Intellectual Property Organization collaborators
Loading World Intellectual Property Organization collaborators